NCT06925893 is a clinical trial in Stage 3 AMD, sponsored by Federico II University.

Who is sponsoring NCT06925893?

NCT06925893 is sponsored by Federico II University.

What condition does NCT06925893 study?

NCT06925893 studies Stage 3 AMD.

Is NCT06925893 still recruiting?

NCT06925893 is currently recruiting now. Last updated 13 April 2025.

Last reviewed 2025-04-13 · How we verify

NCT06925893

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lutein by Scleral Iontophoresis in AMD

Recruiting now Last updated 13 April 2025

What this trial tests

trial in Stage 3 AMD in 80 participants. Currently enrolling.

Timeline

1 November 2024

Primary endpoint
1 December 2024

1 December 2025

Quick facts

Lead sponsor	Federico II University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	80
Start date	1 November 2024
Primary completion	1 December 2024
Estimated completion	1 December 2025
Sites	1 location across Italy

Conditions studied

Stage 3 AMD — all drugs for Stage 3 AMD →

Sponsor

Federico II University

Who can join

Adults 55 to 100, any sex, with Stage 3 AMD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the clinical investigation is to evaluate the performance, safety and degree of tolerability resulting from the use of the iontophoresis medical device in adult subjects diagnosed with AMD stage 3 (AREDS classification) in one or both eyes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Federico II University trials

Trials by the same sponsor.

NCT07437690 — Fall Prevention in Older Adults in an Italian Cohort · not yet recruiting
NCT07282132 — Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter · not yet recruiting
NCT07280286 — Incidence of Intrauterine Adhesions After Myomectomy With Intrauterine Anti-Adhesion Gel · NA · not yet recruiting
NCT07374861 — Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy · recruiting
NCT07314684 — GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06925893 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Federico II University
Last refreshed: 13 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06925893.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing